• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GT Biopharma, Inc. - Common Stock (NQ:GTBP)

6.210 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.210
Bid (Size) 6.350 (400)
Ask (Size) 6.750 (100)
Prev. Close 6.210
Today's Range 6.210 - 6.210
52wk Range 4.910 - 28.75
Shares Outstanding 31,553,892
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
September 15, 2026
Via Chartmill
Top movers in Friday's session ↗
September 11, 2026
Via Chartmill

Performance

52-Week Range 78.4% below 52-week high
6.210
4.9152W Low 28.7552W High
1 Week 17.2% below 1-week high
5.801W Low 7.501W High

GT Biopharma, Inc. - Common Stock (GTBP) traded between $4.91 and $28.75 over the past 52 weeks and last traded at $6.21, 78.4% below its 52-week high. Over the past week it ranged between $5.80 and $7.50.

Past 12 Months
+4.2%
-46.6%
-29.1%
-36.0%
-69.6%
-65.5%
1W +$0.25
1M -$5.42
3M -$2.55
6M -$3.49
YTD -$14.22
1Y -$11.79

GTBP was -65.5% over the past year, -36.0% over six months, -69.6% year to date, +4.2% in the last week.

12 Months vs Market
GTBP
-65.5%
DIA
+11.4%
SPY
+16.2%
QQQ
+21.9%
IWM
+9.5%

Over the past 12 months GTBP returned -65.5% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.9% and IWM (Russell 2000) +9.5%.

Volume & Liquidity
1W
36.9K
1M
81.5K
3M
54.3K
6M
57.5K
YTD
52.7K
1Y
53.2K

GTBP's 3-month average daily volume is 54.3K.

More News

Read More
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
September 11, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
September 04, 2026
Via Chartmill
News headline image
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
June 12, 2026
From Equity Insider
Via GlobeNewswire
News headline image
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 08, 2026
From Biotech Insider
Via GlobeNewswire
These stocks are moving in today's session ↗
May 14, 2026
Via Chartmill
What's going on in today's session ↗
May 14, 2026
Via Chartmill
News headline image
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 14, 2026
From World Street Intelligence
Via GlobeNewswire
Which stocks are gapping on Thursday? ↗
May 14, 2026
Via Chartmill
News headline image
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
May 14, 2026
From USA News Group
Via GlobeNewswire
News headline image
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
May 14, 2026
Via FinancialNewsMedia
Discover the top movers in Thursday's pre-market session. ↗
May 14, 2026
Via Chartmill
News headline image
Replays from RedChip's Biotech Investor Conference Now Available
April 20, 2026
Via ACCESS Newswire
News headline image
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
April 10, 2026
Via ACCESS Newswire
Monday's session: top gainers and losers ↗
February 02, 2026
Via Chartmill
News headline image
THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
January 16, 2026
From Equity Insider
Via GlobeNewswire
News headline image
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
December 24, 2025
From Equity Insider
Via GlobeNewswire
News headline image
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
From USA News Group
Via GlobeNewswire
News headline image
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market
December 11, 2025
From Equity Insider
Via GlobeNewswire
News headline image
GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials
November 19, 2025
Via ACCESS Newswire
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
November 17, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 17, 2025
Via Benzinga
News headline image
The market is filled with gapping stocks in Monday's session. ↗
November 17, 2025
Via Chartmill
News headline image
These stocks are moving in today's pre-market session ↗
November 17, 2025
Via Chartmill

Frequently Asked Questions

Is GT Biopharma, Inc. - Common Stock publicly traded?
Yes, GT Biopharma, Inc. - Common Stock is publicly traded.
What exchange does GT Biopharma, Inc. - Common Stock trade on?
GT Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GT Biopharma, Inc. - Common Stock?
The ticker symbol for GT Biopharma, Inc. - Common Stock is GTBP on the Nasdaq Stock Market
What is the current price of GT Biopharma, Inc. - Common Stock?
The current price of GT Biopharma, Inc. - Common Stock is 6.210
When was GT Biopharma, Inc. - Common Stock last traded?
The last trade of GT Biopharma, Inc. - Common Stock was at 10/14/26 04:00 PM ET
What is the market capitalization of GT Biopharma, Inc. - Common Stock?
The market capitalization of GT Biopharma, Inc. - Common Stock is 195.95M
How many shares of GT Biopharma, Inc. - Common Stock are outstanding?
GT Biopharma, Inc. - Common Stock has 196M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap